
Loading, please wait...

Loading, please wait...

Sinonasal glomangiopericytoma represents an uncommon, low-grade vascular neoplasm that arises from the perivascular modified smooth muscle cells within the nasal cavity and paranasal sinuses. Historically, clinicians grouped this entity with soft tissue hemangiopericytomas. However, current classifications recognize it as a biologically distinct neoplasm exhibiting specialized myoid features and an indolent clinical trajectory. Although most lesions present unilaterally along the ethmoid framework, tumors arising from the posterior nasal septum remain exceptionally infrequent. Consequently, clinicians must recognize its distinct characteristics to avoid diagnostic confusion with inflammatory polyps.
Patients presenting with sinonasal glomangiopericytoma typically describe persistent, unilateral or bilateral nasal obstruction alongside intermittent, spontaneous epistaxis. Because these symptoms mimic benign allergic polyposis or chronic rhinosinusitis, patients often experience significant diagnostic delays. Furthermore, individuals may report secondary nasal symptoms, such as facial fullness, recurrent headaches, hyposmia, and rhinorrhea. On anterior rhinoscopy and diagnostic nasal endoscopy, clinicians usually observe a soft, fleshy, lobulated polypoid mass with a prominent pink or reddish vascular appearance. Because of marked mucosal vascularity, the lesion bleeds readily upon gentle palpation. While solitary unilateral lesions represent the overwhelming majority, bilateral presentation originating from the posterior nasal septum poses unique anatomical challenges. Specifically, septal lesions can expand across the midline to obstruct both choanae, worsening breathing difficulties. Therefore, otolaryngologists must maintain high suspicion when encountering vascular-appearing polypoid masses, prompting early histological verification rather than routine polyp excision.
Preoperative cross-sectional imaging provides vital information regarding lesion boundaries, origin site, and relationship to critical structures. High-resolution computed tomography of the paranasal sinuses demonstrates a well-circumscribed, homogeneous soft-tissue mass. Following contrast administration, the lesion displays robust, homogeneous enhancement because of its intricate blood supply. In addition, computed tomography evaluates adjacent bony margins. Although the mass may induce remodeling or bone thinning along the posterior nasal septum, frank destructive osteolysis rarely occurs. Furthermore, magnetic resonance imaging provides superior soft-tissue distinction. The tumor typically exhibits intermediate signal intensity on T1-weighted sequences and heterogeneous hyperintensity on T2-weighted scans with intense gadolinium enhancement. Magnetic resonance imaging also differentiates neoplastic tissue from retained inflammatory secretions in adjacent sinuses. Moreover, detailed imaging safely excludes orbital extension, sphenoid sinus invasion, or skull base erosion. Consequently, cross-sectional imaging protocols establish an indispensable anatomical foundation for planning endoscopic resection.
Histopathologic examination remains the definitive gold standard for confirming this rare neoplasm. Microscopic evaluation demonstrates an unencapsulated, cellular subepithelial growth composed of uniform, closely packed spindle-shaped cells. In addition, an intact Grenz zone typically separates the neoplastic proliferation from the overlying respiratory epithelium. Branching, thin-walled vascular channels permeate the stroma, creating a distinctive staghorn architecture. Furthermore, the tumor cells display round-to-oval nuclei, fine chromatin, and minimal cellular pleomorphism. Pathologists observe very few mitotic figures and absent necrosis, confirming low-grade biological behavior. Immunohistochemistry plays an indispensable role in distinguishing this entity from histologically similar soft-tissue lesions. Specifically, tumor cells demonstrate strong immunoreactivity for alpha-smooth muscle actin and nuclear beta-catenin. In contrast, the cells consistently show negative staining for CD34, S100 protein, and cytokeratin markers. Therefore, immunohistochemical analysis firmly excludes solitary fibrous tumors, schwannomas, and sarcomas, securing a dependable diagnosis. Consequently, comprehensive immunohistochemical panels prevent diagnostic confusion and unnecessary radical therapies.
Complete surgical resection with clear margins represents the primary therapeutic strategy for sinonasal glomangiopericytoma. Transnasal endoscopic surgery has emerged as the preferred approach, supplanting traditional open transfacial incisions. However, tumors attached to the posterior nasal septum require meticulous anatomical dissection because of constrained working corridors. In substantial vascular tumors, interventional radiologists can perform preoperative angiographic embolization within 24 to 48 hours before surgery. This intervention limits intraoperative hemorrhage and optimizes surgical field visualization. In addition, endoscopic surgeons employ specialized instruments, including bipolar electrocautery, endoscopic coblation, and curved microdebriders, to achieve rapid hemostasis. During resection of posterior septal lesions, the surgeon must remove the underlying mucoperichondrium and adjacent cartilage cuff to guarantee microscopically negative margins. Furthermore, clinicians must carefully preserve unaffected contralateral mucosal flaps when managing bilateral extension to avoid permanent septal perforations. Ultimately, transnasal endoscopic resection achieves outstanding local control, minimal patient discomfort, and rapid functional recovery. Therefore, negative microscopic margins remain paramount during endonasal instrumentation.
Even though sinonasal glomangiopericytoma demonstrates borderline low malignant potential, published literature documents local recurrence rates between 10% and 30%. Incomplete surgical margins represent the single greatest predisposing risk factor for recurrence, particularly in hard-to-reach posterior septal margins. Furthermore, recurrences can emerge many years following primary resection, demanding protracted clinical vigilance. Therefore, otolaryngologists must implement structured long-term surveillance protocols for every patient. Clinicians should conduct rigid transnasal endoscopy every three to six months throughout the first two postoperative years. In addition, baseline magnetic resonance imaging at six to twelve months post-resection establishes a clear comparison point for detecting occult soft-tissue recurrence. If disease recurs locally, revision endoscopic resection remains the primary treatment modality. Moreover, while distant metastasis occurs in less than 5% of cases, tumors demonstrating severe cytologic atypia warrant multidisciplinary oncology consultation. Consequently, diligent follow-up ensures prompt detection of recrudescent disease and maintains excellent long-term survival.
Sinonasal glomangiopericytoma differs fundamentally from soft tissue hemangiopericytoma, which pathologists currently classify as a solitary fibrous tumor. Unlike soft tissue hemangiopericytomas that display widespread CD34 and STAT6 positivity, sinonasal glomangiopericytoma exhibits strong immunopositivity for smooth muscle actin and beta-catenin, confirming myoid perivascular derivation. Furthermore, sinonasal lesions pursue a much more indolent clinical trajectory, rarely metastasizing compared to systemic hemangiopericytomas. Therefore, proper immunohistochemical distinction remains vital for accurate staging, management, and patient counseling.
Most sinonasal glomangiopericytomas arise unilaterally within the ethmoid cells or lateral nasal cavity walls. In contrast, origin from the posterior nasal septum is exceptionally rare and diagnostically deceptive. The posterior septum provides a narrow corridor, allowing the tumor to expand bilaterally through the posterior choana. Consequently, this location demands advanced endoscopic skull base surgical skills to achieve negative margins while protecting contralateral mucoperichondrium and preventing permanent nasal structural perforations.
Because sinonasal glomangiopericytomas feature prominent vascularity, surgical biopsy or excision carries substantial risk of torrential bleeding. Interventional radiologists perform preoperative angiography to map specific arterial feeders, particularly terminal branches of the sphenopalatine or internal maxillary artery. Catheter-directed embolization performed 24 to 48 hours prior to surgical resection dramatically reduces intraoperative blood loss. Consequently, this targeted intervention enhances endoscopic visualization, shortens operative duration, and significantly improves complete microscopic tumor clearance.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Sinonasal glomangiopericytoma is a rare perivascular tumor originating in the sinonasal tract. This article reviews a rare case originating from the posterior nasal septum, examining clinical presentation, imaging, histopathology, and endoscopic management.
Today

The randomized EARLY-RESYNC trial reveals that early left bundle branch pacing combined with guideline-directed medical therapy significantly improves LVEF and reduces LV end-systolic volume compared to medical therapy alone in patients with complete LBBB and mildly reduced ejection fraction (36%-50%).
Today

A comparative evaluation of INNO-LiPA, Cobas 4800, and Amplicor highlights significant assay-dependent variation in high-risk HPV detection, emphasizing the clinical distinction between analytical sensitivity and screening specificity.
Today

Recent data from PGIMER reveals that young adults diagnosed with type 2 diabetes face an aggressive disease trajectory. They encounter severe cardiovascular and microvascular damage within five years, occurring at higher rates than in type 1 diabetes despite lower mean blood glucose levels.
Today

Discover the six core principles of responsible AI in orthopaedics, emphasizing algorithmic fairness, transparency, clinical reliability, and specialist oversight to safeguard patient trust and outcomes.
Today

A novel smartphone-assisted biosensor utilizing molecularly imprinted polymers and catalytic nanozymes offers antibody-free, enzyme-free urinary microalbumin testing, enabling rapid, low-cost point-of-care screening for early chronic kidney disease.
Today